Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93601912 | 9360191 | 2 | F | 20130627 | 20130621 | 20130630 | EXP | HU-ROCHE-1238223 | ROCHE | 0.00 | F | Y | 0.00000 | 20130701 | OT | HU | HU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93601912 | 9360191 | 1 | PS | Xeloda | 1 | ORAL | D | 20896 | 500 | MG | BID | ||||||||
| 93601912 | 9360191 | 2 | SS | Xeloda | 1 | ORAL | D | 20896 | 500 | MG | BID | ||||||||
| 93601912 | 9360191 | 3 | C | Cisplatin | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93601912 | 9360191 | 1 | Gastric cancer |
| 93601912 | 9360191 | 3 | Gastric cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93601912 | 9360191 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93601912 | 9360191 | Asthenia | |
| 93601912 | 9360191 | Dizziness | |
| 93601912 | 9360191 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93601912 | 9360191 | 1 | 20130412 | 201306 | 0 | |
| 93601912 | 9360191 | 2 | 201306 | 0 |